Contineum Therapeutics Inc. Class ACTNM
13F holders, Q3 2025 (September 30)62holders −8
14new positions
21sold out
3famous investors
$11.75avg. 13F price*
At the end of Q3 2025, 62 institutions reported holding Contineum Therapeutics Inc. Class A (CTNM) in their 13F filings, down 8 from Q2 2025. 14 opened new positions and 21 sold out. The largest holders were Ra Capital Management, L.P. ($24.9M), Johnson & Johnson ($23.3M) and Montanova Capital, LLC ($20.2M). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Contineum Therapeutics Inc. Class A
- CUSIP
- 21217B100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $40.5M |
| Exits | 21 | $2.4M |
All 13F filers, Q2 2025 → Q3 2025: 5,125,368 shares bought and 1,333,996 shares sold, net +3,791,372 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 62 holders
| Ra Capital Management, L.P. | 0.31% | New | 2,122,000 | $24.9M |
| Johnson & Johnson | 4.61% | No change | 1,979,173 | $23.3M |
| Montanova Capital, LLC | 0.61% | No change | 1,720,000 | $20.2M |
| Franklin Resources Inc. | 0.00% | Reduce -2.5% | 1,655,548 | $19.5M |
| Vanguard Group Inc. | 0.00% | Add +29.6% | 964,232 | $11.3M |
| Balyasny Asset Management L.P. | 0.02% | New | 951,320 | $11.2M |
| FMR LLC | 0.00% | Reduce -3.4% | 814,871 | $9.6M |
| Sectoral Asset Management Inc. | 5.81% | No change | 800,787 | $9.4M |
| Perceptive Advisors LLC | 0.25% | Add +2.2% | 714,592 | $8.4M |
| HHLR Advisors, LTD. | 0.19% | No change | 669,337 | $7.9M |
| Millennium Management | 0.01% | Add +388.0% | 646,022 | $7.6M |
| Red Tree Management, LLC | 9.04% | No change | 638,158 | $7.5M |
| Samsara Biocapital, LLC | 0.88% | Reduce -3.0% | 571,142 | $6.7M |
| Versant Venture Management, LLC | 3.00% | No change | 542,628 | $6.4M |
| Point72 Asset Management | 0.01% | Reduce -5.4% | 367,645 | $4.3M |
| BlackRock, Inc. | 0.00% | Add +94.6% | 322,031 | $3.8M |
| Geode Capital Management, LLC | 0.00% | Add +196.0% | 211,050 | $2.5M |
| Susquehanna International Group, LLP | 0.00% | Add +914.0% | 204,119 | $2.4M |
| Marshall Wace, LLP | 0.00% | Add +574.5% | 193,491 | $2.3M |
| Silverarc Capital Management, LLC | 0.28% | New | 166,161 | $2.0M |
| Casdin Capital, LLC | 0.15% | No change | 148,333 | $1.7M |
| Eversept Partners, LP | 0.12% | New | 134,619 | $1.6M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +323.1% | 110,178 | $1.3M |
| Morgan Stanley | 0.00% | Add +0.1% | 92,995 | $1.1M |
| ADAR1 Capital Management, LLC | 0.09% | Reduce -53.3% | 77,961 | $916K |
| Baker Bros. Advisors LP | 0.01% | Reduce -75.2% | 77,670 | $913K |
| UBS Group AG | 0.00% | Add +793.7% | 68,504 | $805K |
| State Street Corp. | 0.00% | Add +116.0% | 62,428 | $734K |
| Strategies Wealth Advisors, LLC | 0.06% | No change | 50,000 | $588K |
| Northern Trust Corp. | 0.00% | Add +94.5% | 48,963 | $575K |
| Bridgeway Capital Management, LLC | 0.01% | Add +116.6% | 41,580 | $489K |
| Renaissance Technologies | 0.00% | Add +186.0% | 41,200 | $484K |
| RBF Capital, LLC | 0.02% | No change | 40,000 | $470K |
| Two Sigma Investments, LP | 0.00% | Reduce -37.8% | 37,943 | $446K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -50.5% | 30,135 | $354K |
| Trexquant Investment LP | 0.00% | New | 29,310 | $344K |
| Independent Financial Group, LLC | 0.01% | No change | 27,021 | $317K |
| Acadian Asset Management LLC | 0.00% | Add +390.2% | 26,470 | $308K |
| Baker Ellis Asset Management LLC | 0.03% | New | 19,500 | $229K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -88.7% | 18,496 | $217K |
| Squarepoint Ops LLC | 0.00% | Reduce -85.4% | 13,086 | $154K |
| Bailard, Inc. | 0.00% | New | 12,350 | $145K |
| Mariner, LLC | 0.00% | New | 10,420 | $122K |
| Bank of America Corp. | 0.00% | Add +500.0% | 7,236 | $85K |
| Barclays PLC | 0.00% | Add +273.9% | 6,476 | $76K |
| Wells Fargo & Company | 0.00% | Reduce -28.9% | 5,359 | $63K |
| Royal Bank of Canada | 0.00% | Reduce -12.7% | 2,829 | $33K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 2,560 | $30K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.00% | Reduce -62.1% | 1,834 | $22K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -77.5% | 1,675 | $20K |
| Cwm, LLC | 0.00% | Reduce -54.5% | 1,249 | $15K |
| Simplex Trading, LLC | 0.00% | New | 895 | $10K |
| Group One Trading LLC | 0.00% | New | 500 | $6K |
| Fortitude Family Office, LLC | 0.00% | New | 445 | $5K |
| BNP Paribas Financial Markets | 0.00% | Reduce -26.2% | 220 | $3K |
| Point72 Europe (London) LLP | 0.00% | New | 179 | $2K |
| Optiver Holding B.V. | 0.00% | New | 104 | $1K |
| EverSource Wealth Advisors, LLC | 0.00% | Add +336.4% | 48 | $564 |
| True Wealth Design, LLC | 0.00% | Reduce -69.3% | 38 | $447 |
| Arax Advisory Partners | 0.00% | New | 8 | $94 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $12 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -99.7% | 1 | $12 |
"% of holder's portfolio" is CTNM's weight in each manager's 13F, not the share of Contineum Therapeutics Inc. Class A the manager owns.